1. miRNAs, polyphenols, and chronic disease
- Author
-
Anna Arola-Arnal, Cinta Bladé, Laura Baselga-Escudero, and Maria Josepa Salvadó
- Subjects
Cell ,Metabolic homeostasis ,Computational biology ,Biology ,Non-alcoholic Fatty Liver Disease ,microRNA ,Gene expression ,medicine ,Humans ,Obesity ,Amino Acids ,Genetics ,Regulation of gene expression ,Adipogenesis ,food and beverages ,Polyphenols ,Human cell ,Lipid Metabolism ,Fatty Liver ,MicroRNAs ,medicine.anatomical_structure ,Chronic disease ,Glucose ,Diabetes Mellitus, Type 2 ,Gene Expression Regulation ,Polyphenol ,Cardiovascular Diseases ,Chronic Disease ,Biomarkers ,Food Science ,Biotechnology - Abstract
MicroRNAs (miRNAs) are small noncoding RNAs, approximately 18-25 nucleotides in length, that modulate gene expression at the posttranscriptional level. Thousands of miRNAs have been described, and it is thought that they regulate some aspects of more than 60% of all human cell transcripts. Several polyphenols have been shown to modulate miRNAs related to metabolic homeostasis and chronic diseases. Polyphenolic modulation of miRNAs is very attractive as a strategy to target numerous cell processes and potentially reduce the risk of chronic disease. Evidence is building that polyphenols can target specific miRNAs, such as miR-122, but more studies are necessary to discover and validate additional miRNA targets.
- Published
- 2012